Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-13
2011-12-27
Monshipouri, Maryam (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
08084493
ABSTRACT:
The invention relates to a method of co-administering a peptide or protein drug with an enzyme-resistant PGA-complexone compound orally so to mitigate enzyme attack in the gastrointestinal tract of an animal subject.
REFERENCES:
patent: 6106866 (2000-08-01), Ranney
patent: 6200546 (2001-03-01), Hoffman et al.
patent: 6203775 (2001-03-01), Torchilin et al.
patent: 2008/0253969 (2008-10-01), Yu et al.
Hosny EA et al. “Oral delivery of insulin from enteric-coated capsules containing sodium salicylate” Int J Pharmaceutics 2002;237:71-76.
Sonaje Kiran
Sung Hsing-Wen
Tu Hosheng
GP Medical, Inc.
Monshipouri Maryam
National Tsing Hua University
LandOfFree
Pharmaceutical composition of peptide drug and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition of peptide drug and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of peptide drug and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4254175